MDxHealth SA annual return on equity
2020
2021
2022
2023
2024
2025
MDxHealth SA Return on Equity (ROE) Growth & History (MDXH)
MDxHealth SA's return on equity was −2,440.41% for fiscal 2025.
View full MDxHealth SA company overviewMDxHealth SA annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −2,440.41% | −2095.10 pp |
| 2024 | 2024-12-31 | −345.31% | +176.38 pp |
| 2023 | 2023-12-31 | −521.70% | −365.00 pp |
| 2022 | 2022-12-31 | −156.70% | −46.74 pp |
| 2021 | 2021-12-31 | −109.96% | +114.19 pp |
| 2020 | 2020-12-31 | −224.16% | — |
MDxHealth SA quarterly return on equity
Q1.25
Q2.25
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2025 | 2025-06-30 | −289.95% | — |
| Q1 2025 | 2025-03-31 | −88.51% | — |
MDxHealth SA return on equity trends
Over the last five fiscal years, MDxHealth SA's return on equity decreased from −224.16% to −2,440.41%, a change of −2216.25 percentage points. The latest reported quarter, Q2 2025, shows −289.95%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MDxHealth SA source filings ↗